Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Ons Charfi"'
Autor:
Khouloud Ferchichi, Imen Aouinti, Ahmed Zaiem, Ghozlane Lakhoua, Widd Kaabi, Ons Charfi, Sarrah Kastalli, Riadh Daghfous, Sihem El Aidli
Publikováno v:
Clinical Immunology Communications, Vol 2, Iss , Pp 162-164 (2022)
Introduction: Myocarditis is an adverse reaction discovered after the marketing of SARS-CoV-2 mRNA vaccines. Nevertheless, this effect is not mentioned as an adverse reaction in the summary of product characteristics of other types of vaccines agains
Externí odkaz:
https://doaj.org/article/e5666125a7fc4c689f5e3ce9bebb4122
Autor:
Imen Aouinti, Widd Kaabi, Syrine Ben Hammamia, Riadh Daghfous, Ghozlane Lakhoua, Sihem El Aïdli, Ahmed Zaiem, Sarrah Kastalli, Ons Charfi
Publikováno v:
Current Drug Safety. 18:264-266
Introduction: Liposomal amphotericin B is a widely used broad-spectrum antifungal drug. It was developed to reduce nephrotoxicity and maximize the therapeutic utility of amphotericin B in the treatment of invasive fungal infections. Drug Rash with Eo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fcd69058b5b51208afff5c1f9910def0
https://doi.org/10.2174/1574886316666210727145646
https://doi.org/10.2174/1574886316666210727145646
Autor:
Syrine Ben-Hammamia, Ons Charfi, Anis Belhadj, Amal Bouchrika, Faouzi Chebbi, Ghozlane Lakhoua, Sihem El Aidli
Publikováno v:
Current Drug Safety. 18:267-269
Background: Acenocoumarol is an anticoagulant with numerous drug reactions. We report here, an unusual interaction between acenocoumarol and azathioprine. Case Presentation: A 35-year-old woman, treated with acenocoumarol for thrombosis of the superi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b481795ee34f0fde6f0873771ca1024c
https://doi.org/10.2174/1574886317666220425113613
https://doi.org/10.2174/1574886317666220425113613
Autor:
Khouloud Berrim, Ghozlane Lakhoua, Ahmed Zaiem, Ons Charfi, Imen Aouinti, Sarrah Kastalli, Riadh Daghfous, Sihem El Aidli
Publikováno v:
British Journal of Clinical Pharmacology. 89:574-578
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e994b838a4d0d8684782bedfe811907
https://doi.org/10.1111/bcp.15601
https://doi.org/10.1111/bcp.15601
Autor:
Ghozlane Lakhoua, Khouloud Berrim, Ons Charfi, Widd Kaabi, Ahmed Zaiem, Sarrah Kastalli, Riadh Daghfous, Sihem El Aidli
Publikováno v:
Therapies. 77:627-630
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3cf8c8212be60995207ece2b035b5bb
https://doi.org/10.1016/j.therap.2022.01.013
https://doi.org/10.1016/j.therap.2022.01.013
Autor:
Habiba Mizouni, Sarrah Kastalli, Sihem El Aïdli, Talel Badri, Fares Ben Salem, Imen Aouinti, Ahmed Zaiem, Ons Charfi, Syrine Ben Hammamia, Ghozlane Lakhoua
Publikováno v:
Current Drug Safety. 17:169-175
Background: Iodinated contrast media (ICM) are responsible for multiple side effects, especially hypersensitivity reactions. These reactions can either be authentic allergies or non-allergic hypersensitivity reactions. Skin tests (prick and intraderm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b031c255d180a3f06a39755238b20ff1
https://doi.org/10.2174/1574886316666210923143012
https://doi.org/10.2174/1574886316666210923143012
Autor:
Ines Souilem, Imen Aouinti, Ahmed Zaiem, Ons Charfi, Widd Kaabi, Sarrah Kastalli, Riadh Daghfous, Ghozlane Lakhoua, Sihem El Aidli
Acenocoumarol is the most widely prescribed vitamin K antagonist (VKA) to prevent and treat thromboembolic disorders. It keeps a major place in many indications despite the introduction of new direct oral anticoagulants (DOACs). However, a narrow the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98f193533328f27a28f0b9cdaf44e09a
https://doi.org/10.22541/au.168062646.60217403/v1
https://doi.org/10.22541/au.168062646.60217403/v1
Iopromide is one of the latest generations of non-ionic monomers (NIM) iodinated contrast media (CM). Its use is generally considered to be safe but can occasionally results in adverse events. The frequency of late adverse reactions to non-ionic mono
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54578384388d0737490a44624ee9ae76
https://doi.org/10.22541/au.168001733.35955108/v1
https://doi.org/10.22541/au.168001733.35955108/v1
Autor:
Ines Souilem, Ons Charfi, Imen Hamza, Fatma Zgolli, Sarrah Kastalli, Ghozlane Lakhoua, Sihem El Aidli
Background: Sofosbuvir, a very effective new direct-acting antiviral agent (DAA), has revolutionized the therapeutic management of people infected with hepatitis C virus. It has a low reported rate of side effects. Leukocytoclastic vasculitis can be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dcefd71f332cbd463e3a8840218e0973
https://doi.org/10.22541/au.167786486.61251656/v1
https://doi.org/10.22541/au.167786486.61251656/v1
Autor:
Yasmine Salem Mahjoubi, Imen Aouinti, Ons Charfi, Ahmed Zaiem, Widd Kaabi, Ghozlane Lakhoua, Riadh Daghfous, Sihem El Aidli
Publikováno v:
Therapies.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c802f9bd3c88086cfd04649c1abc2865
https://doi.org/10.1016/j.therap.2023.03.007
https://doi.org/10.1016/j.therap.2023.03.007